Though nuanced, there’s a big difference between a “ketogenic” body and a body “in a state of ketosis.”
A body in a ketogenic state is one actively producing ketones. Ketosis simply marks the presence of ketones in the blood.
Ketones can be produced naturally even though ketones aren’t found in high concentrations in our food. Fasting and dieting aim to achieve a ketogenic state and encourage the body to produce its own ketones, the all-important fuel and signal of a body in ketosis.1
Ketones can be introduced to the body from an external supplement–like HVMN Ketone. Through ketone supplements, the body can receive some of the benefits of ketosis without being in a ketogenic state.
To understand the different ways ketones enter the blood, it’s important to look at the basic biology of ketones themselves.
There are two ways to achieve ketosis, which is usually defined as having blood ketone levels elevated >0.5mM.
Endogenous ketones are produced by the liver during a ketogenic state, this usually occurs when fasting or following a ketogenic diet. One must strictly follow the low-carb, high-fat diet, which can be difficult in today’s society that has a long-standing love affair with carbohydrates.
Exogenous ketones are ketones consumed through a nutritional supplement. They can deliver a state of ketosis without changing the diet.
It’s important to note that exogenous ketones don’t trigger natural ketone production, meaning they don’t put you in a ketogenic state. A ketogenic state can only be achieved by the body naturally producing ketones. Exogenous ketones do, however, promote a state of ketosis, which means that blood ketones levels are elevated.
Most forms of exogenous ketones deliver beta hydroxybutyrate (BHB) rather than acetoacetate (AcAc). This is due to a combination of factors:
In short, the body usually chooses to transport more of the ketones in the blood as BHB instead of AcAc. This is likely because BHB not only is better for cell energy production, but also an inherently more stable ketone molecule.
Optical isomerism describes the occurrence of compounds made from the same number and order of atoms, but different in the 3D arrangement of the atoms’ bonds. This happened via evolution, allowing compounds to be used (and created) differently.
There are two optical isoforms of BHB, called D-BHB and L-BHB. Think of it like this: our left and right hands have identical components (put together in the same order) but can’t overlay perfectly.
Because of the subtle differences between D- and L-BHB, the body can’t use the two forms in the same way.
The body releases D-BHB into the blood and uses it for energy. While there is L-BHB inside our cells, the body does not release significant amounts of L-BHB into the blood3 and really, it’s unclear how the human body uses L-BHB. Studies in rats suggest it’s not readily used as fuel, and is mainly used to synthesize fats.4,5
L-BHB appears to be a “weaker” form of D-BHB, both regarding its ability to provide energy, but also in its ability to act as an antioxidant.6
BHB is delivered through two main classes of exogenous ketone supplements: ketone esters and ketone salts. Medium Chain Triglycerides (MCTs) are also used to artificially raise blood ketone levels by providing a source of fat that is easily converted into BHB–but there is no BHB in MCT itself.
Overall, ketone salts and MCTs don’t increase ketone levels like ketone esters. Let’s analyze why.
Ketone salts are a powder containing BHB bound to a mineral salt (most commonly sodium or calcium) or sometimes an amino acid (such as lysine or arginine). The powdered salts are dissolved into a liquid to make it easier to consume. Published human clinical trials report blood BHB levels of 0.6 - 0.8 mM after ketone salt drinks.7,8
Despite the recent growth of the ketone salt market, there is very little published work looking at the effects of these drinks on any biomarkers or performance measures in humans. Several studies of ketone salts have been carried out in rats,14,15,16 with blood BHB levels after salt drinks being relatively low (> 0.5 mM). The earliest human studies of ketone salts were a small number of clinical studies in sick children,17,18 who were being treated with ketone salts to help with inborn metabolic defects. The maximal BHB levels seen were 0.4 - 2.5 mM and doctors noticed improvements in their clinical symptoms.
In a recent study of healthy young adults, ketone salts gave a peak D-BHB of 1 mM, whereas the same amount of BHB as a ketone ester (BD-BHB) raised blood BHB to 2.8 mM.9 Also noted was a high amount of L-BHB in the blood after salt drinks (> 2 mM). L-BHB took far longer to be removed from the blood compared with D-BHB, indicating that L-BHB likely has a different metabolic fate to D-BHB.
Recently, four published studies investigated the effects of ketone salts in athletes (total n = 22).7,8,19,12 None of these studies found an improvement in performance; in one study, performance actually decreased by 7%. Blood BHB levels peaked between 0.5 and 0.8 mM in these studies. GI distress (nausea, diarrhoea, vomiting, and lightheadedness) was reported in high percentages of athletes taking ketone salts alongside exercise (78% and 60%).12,13
Some commercial ketone salt supplements contain other ingredients such as MCT, caffeine, and carbohydrate. It is unknown if adding these extra ingredients will help or hinder the effects of the ketone salt consumed.
Medium chain triglycerides don’t contain ketones themselves–they’re actually fat molecules (made up of glycerol joined to 3 medium-length fatty acids). In this case, “medium” chain length means that there are 6-12 carbons in the fatty acid chain.
Ketones form as a result of the breakdown of MCT fat molecules by the body. Coconut oil is a natural source of medium chain triglycerides, but MCTs can also be taken as synthetically purified oils.
Medium chain triglycerides are processed by the body differently compared to long-chain fats. Long-chain fats are absorbed and released into the blood via the lymphatic system, bypassing the liver. However, medium-chain triglycerides are transported straight to the liver in the blood. There, they are either used directly as a source of energy or turned into ketones.
There are a large number of research papers demonstrating that MCTs are safe to consume. However, gastrointestinal side effects (such as diarrhea) are common, especially when consuming high amounts.20,21
There is not a clear answer as to which chain length of fatty acids comprising MCT (6-12 carbon chain length) is best at raising blood BHB levels. The available research suggests that C6 (caproic) and C8 (capric) fatty acids have the greatest effects on blood BHB.22,23
Ketone esters are liquids that contain BHB or AcAc bound to another ketone precursor (such as butanediol or glycerol) by an ester bond. There are several types of ketone ester in existence and they affect the body differently: the D-BHB Ketone Monoester (HVMN Ketone) and the AcAc Diester.
It’s important to distinguish which ketone ester is being used because there are differences in their physical characteristics and metabolic effects.
Contrary to what you might think, ketone esters aren’t a recent discovery. The first ketone ester was developed in the late 1970’s (a glycerol and acetoacetate ester)30 and other types of ester were developed in the mid-1990’s (RS-1,3-butanediol-acetoacetate mono- and di-esters).4
Currently, two different ketone esters are under active investigation in rodents and humans.
One ketone ester compound was developed at the University of South Florida. This is an acetoacetate diester, made up of two molecules of acetoacetate bound to one molecule of D/L-butanediol (See Figure 2B).
In rodents, the acetoacetate diester raises blood D-BHB to 1 - 4 mM and blood AcAc to up to 5 mM.31 There is one published study of this ketone ester in humans, with results showing a 2% decrease in 31km cycling time trial performance.29 This is likely due to the high rate of side effects of this ester studied. Other factors may have included low levels of BHB (<2 mM), the short high-intensity time trial used, or the use of AcAc vs. BHB.32
The other ketone ester, the BHB-monoester, was invented by a DARPA program to enhance US soldier endurance and performance. A research group at the University of Oxford and NIH received funding from the US Military to develop R-1,3-butanediol-R-3-hydroxybutyrate (BD-BHB, See Figure 2A).
This is the ketone ester in HVMN Ketone.
When taken as a drink, the ester bonds are broken by gut esterase enzymes, releasing butanediol and D-BHB into the blood. Butanediol (which is approved by the FDA as a food) is an alcohol that is structurally similar to BHB, which is metabolized by the liver to form D-BHB. Both molecules of D-BHB reach the circulation, as the liver is unable to use ketones. Consumption of this ketone ester reliably and safely elevates blood ketone levels in humans with few GI and systemic side effects.24
This ester has been approved by the FDA for use as food, and cleared for use in athletes by the World Anti Doping Agency. HVMN Ketone is batch tested as part of the NSF ‘safe for sport’ program. There are seven published human studies, in which 128 people have shown:
It can be confusing to pick which ketone supplement suits your needs, especially if you’re an athlete. There are a few extra things to consider.
Elite athletes must take extra precautions with sports foods (e.g., energy bars and drinks) and supplements (e.g., caffeine, creatine) to ensure they don’t violate anti-doping rules.
First, the specific compound itself must not be prohibited by the World Anti Doping Agency (WADA). Then, an independent laboratory must test each batch of the food/supplement to confirm no contamination with a banned substance. This is important because 44% of failed drugs tests in the UK in 2012 were caused by contaminated supplements. In the US, the major independent testing laboratory is NSF Safe for Sport. (Informed Sport also offers testing, and is more popular outside the US).
Ketone supplements are not currently banned by WADA, although as far as we are aware, the only ketone product to have been explicitly cleared by WADA is the BHB monoester in HVMN Ketone. Some of the commercially available ketone salts are tested by Informed Sport, and HVMN Ketone is tested by NSF Safe for Sport. Current customers include elements within the US Special Operations Command, Grand Tour Cycling teams competing in the Tour de France, NFL teams, World Tour Tennis players, professional triathletes, USA Olympic hopefuls and more.
If you’re not a competing athlete, questions should circle around performance, quality and experience. When considering ketone supplements, ask yourself:
Exogenous ketones, like HVMN Ketone, are a new and exciting dietary tool.
Of course, for optimal health and performance, you should always aim to eat a healthy and balanced diet. Contrary to some press, even diligent dieting and use of ketone supplements can quickly be undone by a weekend of pizza and doughnuts.
|1.||Newman, J.C., and Verdin, E. (2017). Ketone bodies as signaling metabolites. Trends Endocrinol. Metab. 25, 42-52.|
|2.||Cahill, G.F., Jr. (2006). Fuel metabolism in starvation. Annu Rev Nutr 26, 1-22.|
|3.||Reed, W.D., and Ozand, P.T. (1980). Enzymes of L-(+)-3-hydroxybutyrate metabolism in the rat. Arch Biochem Biophys 205, 94-103.|
|4.||Desrochers, S., David, F., Garneau, M., Jette, M., and Brunengraber, H. (1992). Metabolism of R-1,3-Butanediol and S-1,3-Butanediol in Perfused Livers from Meal-Fed and Starved Rats. Biochem. J. 285, 647-653.|
|5.||Webber, R.J., and Edmond, J. (1977). Utilization of L(+)-3-Hydroxybutyrate, D(-)-3-Hydroxybutyrate, Acetoacetate, and Glucose for Respiration and Lipid-Synthesis in 18-Day-Old Rat. J Biol Chem 252, 5222-5226.|
|6.||Haces, M.L., Hernandez-Fonseca, K., Medina-Campos, O.N., Montiel, T., Pedraza-Chaverri, J., and Massieu, L. (2008). Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions. Exp. Neurol. 211, 85-96.|
|7.||Rodger, S., Plews, D., Laursen, P., and Driller, M. (2017). The effects of an oral β-hydroxybutyrate supplement on exercise metabolism and cycling performance.|
|8.||O’Malley, T., Myette-Cote, E., Durrer, C., and Little, J.P. (2017). Nutritional ketone salts increase fat oxidation but impair high-intensity exercise performance in healthy adult males. Applied Physiology, Nutrition, and Metabolism, 1-5.|
|9.||Stubbs, B.Cox, P.; Evans, R.; Santer, P.; Miller, J.; Faull, O.; Magor-Elliott, S.; Hiyama, S.; Stirling, M.; Clarke, K. (2017). On the metabolism of exogenous ketones in humans. Front. Physiol.|
|10.||Strazzullo, P., D'Elia, L., Kandala, N.B., and Cappuccio, F.P. (2009). Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 339, b4567.|
|11.||Rabast, U., Vornberger, K.H., and Ehl, M. (1981). Loss of weight, sodium and water in obese persons consuming a high- or low-carbohydrate diet. Ann. Nutr. Metab. 25, 341-349.|
|12.||Evans M, Patchett E, Nally R, Kearns R, Larney M, Egan B. Effect of acute ingestion of β-hydroxybutyrate salts on the response to graded exercise in trained cyclists. Eur J Sport Sci. 2018:1-11.|
|13.||Tobias Fischer, Ulrike Och, Ira Klawon, et al., “Effect of a Sodium and Calcium DL-β-Hydroxybutyrate Salt in Healthy Adults,” Journal of Nutrition and Metabolism, vol. 2018, Article ID 9812806, 8 pages, 2018. https://doi.org/10.1155/2018/9812806.|
|14.||Kesl, S.L., Poff, A.M., Ward, N.P., Fiorelli, T.N., Ari, C., Van Putten, A.J., Sherwood, J.W., Arnold, P., and D’Agostino, D.P. (2016). Effects of exogenous ketone supplementation on blood ketone, glucose, triglyceride, and lipoprotein levels in Sprague–Dawley rats. Nutr. Metab. 13, 9.|
|15.||Ari, C., Kovács, Z., Juhasz, G., Murdun, C., Goldhagen, C.R., Koutnik, A.P., Poff, A.M., Kesl, S.L., and D’Agostino, D.P. (2016). Exogenous Ketone Supplements Reduce Anxiety-Related Behavior in Sprague-Dawley and Wistar Albino Glaxo/Rijswijk Rats. Front. Mol. Neurosci. 9, 137.|
|16.||Caminhotto, R.d.O., Komino, A.C.M., de Fatima Silva, F., Andreotti, S., Sertié, R.A.L., Boltes Reis, G., and Lima, F.B. (2017). Oral β-hydroxybutyrate increases ketonemia, decreases visceral adipocyte volume and improves serum lipid profile in Wistar rats. Nutr. Metab. 14, 31.|
|17.||Plecko, B., Stoeckler-Ipsiroglu, S., Schober, E., Harrer, G., Mlynarik, V., and Gruber, S. (2002). Oral beta-hydroxybutyrate supplementation in two patients with hyperinsulinemic hypoglycemia: monitoring of beta-hydroxybutyrate levels in blood and cerebrospinal fluid, and in the brain by in vivo magnetic resonance spectroscopy. Pediatr Res 52.|
|18.||Van Hove, J.L.K., Grunewald, S., Jaeken, J., Demaerel, P., Declercq, P.E., Bourdoux, P., Niezen-Koning, K., Deanfeld, J.E., and Leonard, J.V. (2003). D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD). Lancet 361, 1433-1435.|
|19.||Waldman HS, Krings B, Basham SA, Smith JW, Fountain BJ, McAllister MJ. Effects of a 15-Day Low Carbohydrate, High-Fat Diet in Resistance-Trained Men. (1533-4287 (Electronic)).|
|20.||Henderson, S.T., Vogel, J.L., Barr, L.J., Garvin, F., Jones, J.J., and Costantini, L.C. (2009). Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond) 6, 31.|
|21.||Ivy JL, Costill DL, Fink WJ, Maglischo E. Contribution of Medium and Long Chain Triglyceride Intake to Energy Metabolism During Prolonged Exercise. Int J Sports Med. 1980;01(01):15-20.|
|22.||McGarry, J.D., and Foster, D.W. (1971). The Regulation of Ketogenesis from Octanoic Acid: THE ROLE OF THE TRICARBOXYLIC ACID CYCLE AND FATTY ACID SYNTHESIS. J Biol Chem 246, 1149-1159.|
|23.||Schultz, L.H., Smith, V.R., and Lardy, H.A. (1949). The Effect of the Administration of Various Fatty Acids on the Blood Ketone Levels of Ruminants. J. Dairy Sci. 32, 817-822.|
|24.||Clarke, K., Tchabanenko, K., Pawlosky, R., Carter, E., Todd King, M., Musa-Veloso, K., Ho, M., Roberts, A., Robertson, J., Vanitallie, T.B., et al. (2012). Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul. Toxicol. Pharmacol. 63, 401-408.|
|25.||Shivva, V., Cox, P.J., Clarke, K., Veech, R.L., Tucker, I.G., and Duffull, S.B. (2016). The Population Pharmacokinetics of d-β-hydroxybutyrate Following Administration of (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate. The AAPS journal, 1-11.|
|26.||Cox, P.J., Kirk, T., Ashmore, T., Willerton, K., Evans, R., Smith, A., Murray, Andrew J., Stubbs, B., West, J., McLure, Stewart W., et al. (2016). Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes. Cell Metabolism 24, 1-13.|
|27.||Holdsworth, D.A., Cox, P.J., Kirk, T., Stradling, H., Impey, S.G., and Clarke, K. (2017). A Ketone Ester Drink Increases Postexercise Muscle Glycogen Synthesis in Humans. Med Sci Sports Exerc.|
|28.||Vandoorne, T., De Smet, S., Ramaekers, M., Van Thienen, R., De Bock, K., Clarke, K., and Hespel, P. (2017). Intake of a Ketone Ester Drink during Recovery from Exercise Promotes mTORC1 Signaling but Not Glycogen Resynthesis in Human Muscle. Front. Physiol. 8, 310.|
|29.||Leckey, J.J., Ross, M.L., Quod, M., Hawley, J.A., and Burke, L.M. (2017). Ketone Diester Ingestion Impairs Time-Trial Performance in Professional Cyclists. Front. Physiol. 8, 806.|
|30.||Birkhahn RH, Border JR.Intravenous feeding of the rat with short chain fatty acid esters. II. Monoacetoacetin. Am J Clin Nutr. 1978 Mar;31(3):436-41.|
|31.||D'Agostino, D.P., Pilla, R., Held, H.E., Landon, C.S., Puchowicz, M., Brunengraber, H., Ari, C., Arnold, P., and Dean, J.B. (2013). Therapeutic ketosis with ketone ester delays central nervous system oxygen toxicity seizures in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304, R829-836.|
|32.||Stubbs BJ, Koutnik AP, Poff AM, Ford KM, D'Agostino DP. Commentary: Ketone Diester Ingestion Impairs Time-Trial Performance in Professional Cyclists. Front Physiol. 2018;9:279.|
|33.||Stubbs BJ, Cox PJ, Evans RD, Cyranka M, Clarke K, De wet H. A Ketone Ester Drink Lowers Human Ghrelin and Appetite. Obesity (Silver Spring). 2018;26(2):269-273.|
|34.||Myette-Cote E, Neudorf H, Rafiei H, Clarke K, Little JP. Prior ingestion of exogenous ketone monoester attenuates the glycaemic response to an oral glucose tolerance test in healthy young individuals. LID - 10.1113/JP275709 [doi]. 2018(1469-7793 (Electronic)).|
|35.||Newport, M.T., VanItallie, T.B., Kashiwaya, Y., King, M.T., and Veech, R.L. (2015). A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association 11, 99-103.|
Once a week, we'll send you the most compelling research, stories and updates from the world of human enhancement.